Key Takeaways
- Nourish’s GLP-1 support pathways help patients improve adherence, reduce side effects, and maintain weight loss after stopping medication.
- Patients working with Nourish dietitians saw 33% more weight loss, better medication adherence, and fewer side effects compared to those without support.
- Nourish’s approach delivers real-world outcomes and potential cost savings, as highlighted in a white paper based on a survey of 3,700+ patients.
GLP-1s have revolutionized obesity treatment, with clinical trails pointing to significantly greater weight loss and clinically meaningful benefits for obesity related chronic disease. In the real world, however, effectiveness of these medications has been limited by several challenges including lack of medication adherence, risk of rebound weight, and high costs.
Nourish’s GLP-1 Companion and GLP-1 Off-Ramp Pathways are designed to help people get more from their treatment, reduce side effects, and maintain progress even after stopping medication.
The efficacy of these clinical pathways is grounded in real-world outcomes from a survey of 3,700+ patients:
- Nourish patients on GLP-1s lost 33% more weight (vs. patients who did not work with a Nourish RD)
- 64% of Nourish patients reported improvements in side effects like nausea and GI discomfort
- Nourish patients on GLP-1s reported better adherence (15% missing a dose vs. 24%) vs. patients who did not work with a Nourish RD
- 60% of Nourish patients who discontinued GLP-1s found Nourish helpful in maintaining their weight post-treatment
Nourish’s white paper demonstrates how Nourish’s pathways can enhance health outcomes and deliver cost savings for patients exploring, taking, or stopping GLP-1s.
Click here to learn more about how Nourish can support patients on their GLP-1 journey.
Do you have any of these insurances?
